Costco Wholesale and Beef Products are two companies that have opted to take action rather than wait for the US government to uphold its promise to strengthen consumers’ protection from E. coli. E. coli prevention previously concentrated on one prevalent strain of the bacteria, O157:H7. The US Department of Agriculture’s proposal for how to address […]
Despite drug R&D spending falling to a three-year low of $68 billion in 2010, pharmaceutical sales grew to a record $856 billion. Drug companies are spending 22% of global sales, of which only 5% come from products new to market over the past five years, on R&D. In 2010, 21 new molecular entities were introduced, […]
Renewable energy investments continued to grow in 2010, according to the latest “Global Trends in Renewable Energy Investment” report. In 2010, $211 billion was spent on renewable energy, an increase of almost a third due to stimulus funding, new guidelines, wind farm development and small-scale rooftop solar PV installation. Asset financing grew 19% to $128 […]
R&D spending bounced back last year following the recession. In 2010, total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and laboratory product companies grew 11.3% to $1.54 billion, compared with 2.3% growth for the same companies in 2009. R&D spending for these companies was accelerated by higher […]
First-quarter revenues for the IBO Lab Equipment/Consumables Index grew 3.9%, 2.9% organically, to $3,970.74 million. Operating profit improved 4.0% to $707.69 million, and operating margin added 30 basis points to 18.2% of sales. Diploma was removed from the Index, and Merck Millipore was added. Biohit’s first-quarter sales grew 9.9%, 7.5% excluding currency, to €10.4 million […]
Venlo, the Netherlands and Melbourne, Australia 7/11/11— QIAGEN has increased its offer to acquire diagnostics maker Cellestis (see IBO 4/15/11). QIAGEN increased the offer price by 7% to AUD 3.80 ($3.96 =AUD 0.96 = $1) per share for a value of $374 million. QIAGEN stated that this would be its final offer absent a competing […]
Holliston, MA 7/1/11—Harvard Bioscience has acquired the preclinical research business of CMA Microdialysis through a purchase of assets. Microdialysis is used for in vivo sampling and monitoring of organs and tissues. “The acquisition of CMA Microdialysis’ preclinical business provides Harvard with a leading technology to add to our line of specialized tools for biological research,” […]
Stockholm, Sweden 7/6/11; Västra Frölunda, Sweden 7/6/11; Ballerup, Denmark 7/6/11—Biolin Scientific has agreed to acquire Sophion Bioscience, a provider of automated patch clamp products for ion channel research, for DKK 145 million ($28.1 million = DKK 5.15 = $1) and an additional DKK 10 million ($1.9 million) related to sales milestones. Based in Copenhagen, Denmark, […]
Santa Clara, CA 7/6/11—Affymetrix has announced that it expects second-quarter revenues of $64–$65 million. This would be a 10%–11% decrease from a year ago. Product revenue is expected to be $58–$59 million for a 9%–11% decline. Product revenue includes $55 million in consumables sales and $3.5 million in instrument sales. Service revenue is estimated to […]
White Plains, NY and Yellow Springs, OH 7/11/11—ITT has definitively agreed to acquire, via merger, YSI. YSI develops and manufactures sensors, instruments, software and data collection platforms for environmental water monitoring. YSI had 2010 revenues of $101 million and employs 390 people with locations in the US, Europe and Asia. YSI will join ITT Analytics, […]
Pay Invoice
Latest Blogs
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
-
10x Genomics Debuts First Plate-Based Assay
November 21, 2025 3:50 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
